101 related articles for article (PubMed ID: 20981700)
21. 2,4-Diamino-N10-methylpteroic acid (DAMPA) crystalluria in a patient with osteosarcoma treated with carboxypeptidase-G2 rescue after high-dose methotrexate-induced nephrotoxicity.
Berga F; Luna P; Martorell C; Rey J; Gomila I; Gimenez S; Costa-Bauza A; Elorza MÁ; Sánchez I; Grases F; Barceló B
Clin Chim Acta; 2018 Dec; 487():1-5. PubMed ID: 30205081
[TBL] [Abstract][Full Text] [Related]
22. Treatment of accidental intrathecal methotrexate overdose with intrathecal carboxypeptidase G2.
Widemann BC; Balis FM; Shalabi A; Boron M; O'Brien M; Cole DE; Jayaprakash N; Ivy P; Castle V; Muraszko K; Moertel CL; Trueworthy R; Hermann RC; Moussa A; Hinton S; Reaman G; Poplack D; Adamson PC
J Natl Cancer Inst; 2004 Oct; 96(20):1557-9. PubMed ID: 15494606
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of glucarpidase in subjects with normal and impaired renal function.
Phillips M; Smith W; Balan G; Ward S
J Clin Pharmacol; 2008 Mar; 48(3):279-84. PubMed ID: 18192538
[TBL] [Abstract][Full Text] [Related]
24. Renal dysfunction during and after high-dose methotrexate.
Green MR; Chamberlain MC
Cancer Chemother Pharmacol; 2009 Mar; 63(4):599-604. PubMed ID: 18504579
[TBL] [Abstract][Full Text] [Related]
25. Analytical interference in the therapeutic drug monitoring of methotrexate.
Oudart JB; Marquet B; Feliu C; Gozalo C; Djerada Z; Millart H
Ann Biol Clin (Paris); 2016 Jun; 74(3):333-7. PubMed ID: 27101631
[TBL] [Abstract][Full Text] [Related]
26. Voraxaze treats toxic methotrexate levels.
Belavic JM
Nurse Pract; 2012 Sep; 37(9):15-6. PubMed ID: 22922716
[No Abstract] [Full Text] [Related]
27. Difficulty measuring methotrexate in a patient with high-dose methotrexate-induced nephrotoxicity.
Al-Turkmani MR; Law T; Narla A; Kellogg MD
Clin Chem; 2010 Dec; 56(12):1792-4. PubMed ID: 21119035
[No Abstract] [Full Text] [Related]
28. Successful carboxypeptidase G2 rescue in delayed methotrexate elimination due to renal failure.
Zoubek A; Zaunschirm HA; Lion T; Fischmeister G; Vollnhofer G; Gadner H; Pillwein K; Schalhorn A; Bode U
Pediatr Hematol Oncol; 1995; 12(5):471-7. PubMed ID: 8519632
[TBL] [Abstract][Full Text] [Related]
29. Treatment of osteosarcoma.
Waters KD
Clin Exp Pharmacol Physiol Suppl; 1979; 5():11-6. PubMed ID: 318496
[TBL] [Abstract][Full Text] [Related]
30. Fixed-Dose Glucarpidase for Toxic Methotrexate Levels and Acute Kidney Injury in Adult Lymphoma Patients: Case Series.
Truong H; Leung N
Clin Lymphoma Myeloma Leuk; 2021 Jun; 21(6):e497-e502. PubMed ID: 33563580
[No Abstract] [Full Text] [Related]
31. Preoperative administration of high-dose methotrexate for osteosarcoma.
Chan KW; Knowling MA; Duncan CP; Morton KS
Can J Surg; 1984 May; 27(3):305-7, 309. PubMed ID: 6586272
[TBL] [Abstract][Full Text] [Related]
32. Using a lower dose of glucarpidase to reduce plasma levels of methotrexate.
Widemann BC
Clin Adv Hematol Oncol; 2013 May; 11(5):324-5. PubMed ID: 23880720
[No Abstract] [Full Text] [Related]
33. Treatment of methotrexate intoxication with various modalities of continuous extracorporeal therapy and glucarpidase.
Vilay AM; Mueller BA; Haines H; Alten JA; Askenazi DJ
Pharmacotherapy; 2010 Jan; 30(1):111. PubMed ID: 20030480
[TBL] [Abstract][Full Text] [Related]
34. Reply to: Glucarpidase for the Treatment of Methotrexate-Induced Renal Dysfunction and Delayed Methotrexate Excretion.
Widemann BC
Pediatr Blood Cancer; 2016 Feb; 63(2):366. PubMed ID: 26488622
[No Abstract] [Full Text] [Related]
35. Liquid chromatography-tandem mass spectrometry (LC-MS-MS) method for monitoring methotrexate in the setting of carboxypeptidase-G2 therapy.
Kumar VS; Law T; Kellogg M
Methods Mol Biol; 2010; 603():359-63. PubMed ID: 20077087
[TBL] [Abstract][Full Text] [Related]
36. Commentary.
Milone MC
Clin Chem; 2010 Dec; 56(12):1795-6. PubMed ID: 21119036
[No Abstract] [Full Text] [Related]
37. Commentary.
Fox E; Balis FM
Clin Chem; 2010 Dec; 56(12):1795. PubMed ID: 21119037
[No Abstract] [Full Text] [Related]
38. Enzymatic cleavage of methotrexate provides a method for prevention of drug toxicity.
Chabner BA; Johns DG; Bertino JR
Nature; 1972 Oct; 239(5372):395-7. PubMed ID: 12635300
[No Abstract] [Full Text] [Related]
39. Influence of high-dose methotrexate therapy (HD-MTX) on glomerular and tubular kidney function.
Hempel L; Misselwitz J; Fleck C; Kentouche K; Leder C; Appenroth D; Rost M; Zintl F
Med Pediatr Oncol; 2003 Jun; 40(6):348-54. PubMed ID: 12692801
[TBL] [Abstract][Full Text] [Related]
40. [Evaluation of severe side effects of high-dose methotrexate in osteosarcoma].
Umeda T; Takada N; Hodaka E; Endoh F; Ishii T
Gan To Kagaku Ryoho; 1984 Feb; 11(2):285-94. PubMed ID: 6582805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]